Dipeptidyl Peptidase-4 and Adolescent Idiopathic Scoliosis: Expression in Osteoblasts

Código QR

Dipeptidyl Peptidase-4 and Adolescent Idiopathic Scoliosis: Expression in Osteoblasts

Abstract It has been proposed that girls with adolescent idiopathic scoliosis (AIS) tend to have a taller stature and a lower body mass index. Energy homeostasis, that is known to affect bone growth, could contribute to these characteristics. In circulation, dipeptidyl peptidase-4 (DPP-4) inactivate...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Emilie Normand, Anita Franco, Alain Moreau, Valérie Marcil
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2017
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/39ecfbac05f2488ba6eb6d1dbf57f2f4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Urate-lowering effects of dipeptidyl peptidase-4 inhibitors
por: Taras S. Panevin, et al.
Publicado: (2020)

Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose
por: Das SS, et al.
Publicado: (2014)

The Mutational Landscape of <i>PTK7</i> in Congenital Scoliosis and Adolescent Idiopathic Scoliosis
por: Zhe Su, et al.
Publicado: (2021)

Predictors of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Taiwanese Patients with Type 2 Diabetes Mellitus
por: Lin YH, et al.
Publicado: (2019)

Dipeptidyl peptidase 4 promotes peritoneal fibrosis and its inhibitions prevent failure of peritoneal dialysis
por: Yi-Chen Li, et al.
Publicado: (2021)

Emerging Roles of Dipeptidyl Peptidase-4 Inhibitors in Delaying the Progression of Type 1 Diabetes Mellitus
por: Gurgel Penaforte-Saboia J, et al.
Publicado: (2021)

The role of dipeptidyl peptidase 4 inhibitors in fat metabolism in patients with type 2 diabetes and obesity
por: Aleksander Sergeevich Ametov, et al.
Publicado: (2015)

Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease
por: Chen L, et al.
Publicado: (2020)

Three-dimensional vertebral wedging in mild and moderate adolescent idiopathic scoliosis.
por: Sophie-Anne Scherrer, et al.
Publicado: (2013)

Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain
por: Kornél Király, et al.
Publicado: (2018)

Inhibition of dipeptidyl peptidase-4: The mechanisms of action and clinical use of vildagliptin for the management of type 2 diabetes
por: Galina Smushkin, et al.
Publicado: (2009)

Dipeptidyl peptidase-IV inhibitory action of Calebin A: An in silico and in vitro analysis
por: Nehru Sai Suresh Chalichem, et al.
Publicado: (2021)

Asymmetrical activation and asymmetrical weakness as two different mechanisms of adolescent idiopathic scoliosis
por: Yulhyun Park, et al.
Publicado: (2021)

In vivo deformation of anatomically pre-bent rods in thoracic adolescent idiopathic scoliosis
por: Hideki Sudo, et al.
Publicado: (2021)

Spirometry Examination of Adolescents with Thoracic Idiopathic Scoliosis: Is Correction for Height Loss Useful?
por: Katarzyna Politarczyk, et al.
Publicado: (2021)

Segmental Derotation Using Alternating Pedicular Screws in Treatment of Adolescent Idiopathic Scoliosis
por: Mohamed Wafa, et al.
Publicado: (2012)

Dipeptidyl peptidase-4 inhibitors, pancreatic cancer and acute pancreatitis: A meta-analysis with trial sequential analysis
por: Lana C. Pinto, et al.
Publicado: (2018)

Targeted inactivation of dipeptidyl peptidase 9 enzymatic activity causes mouse neonate lethality.
por: Margaret G Gall, et al.
Publicado: (2013)

Analysis of the Degree of Involvement of the Lower Limb Muscles in the Pathological Process in Adolescents with Idiopathic Scoliosis
por: E. N. Shchurova, et al.
Publicado: (2021)

Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
por: Han E, et al.
Publicado: (2020)

Initial investigation of efficacy and safety of a new dipeptidyl peptidase-4 inhibitor, gosogliptin, for type 2 diabetes in Russia
por: Lyudmila Viktorovna Nedosugova, et al.
Publicado: (2014)

Molecular Dynamics Simulations Study of the Interactions between Human Dipeptidyl-Peptidase III and Two Substrates
por: Shitao Zhang, et al.
Publicado: (2021)

Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials
por: Ming Zhao, et al.
Publicado: (2017)

Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarction
por: Jing Wei Li, et al.
Publicado: (2017)

Possible applications of gliptins (dipeptidyl peptidase-4 inhibitors) in patients with type 2 diabetes mellitus on the various modes of insulin therapy
por: Gagik Radikovich Galstyan, et al.
Publicado: (2015)

Comparative risk of musculoskeletal adverse reactions among new users of dipeptidyl peptidase-4 inhibitors: A retrospective cohort study
por: Taehwan Park, et al.
Publicado: (2021)

Sclerostin and Its Involvement in the Pathogenesis of Idiopathic Scoliosis
por: Elias S. Vasiliadis, et al.
Publicado: (2021)

Gliptins vs. Milk-derived Dipeptidyl-Peptidase IV Inhibiting Biopeptides: Physicochemical Characterization and Pharmacokinetic Profiling
por: Jorge Andrés Barrero, et al.
Publicado: (2021)

Dipeptidyl peptidase III as a DNA marker to investigate epidemiology and taxonomy of Old World Leishmania species.
por: Insaf Bel Hadj Ali, et al.
Publicado: (2021)

Dipeptidyl peptidase-4 inhibitor cardiovascular safety in patients with type 2 diabetes, with cardiovascular and renal disease: a retrospective cohort study
por: Sheriza Baksh, et al.
Publicado: (2021)

Pelvic morphology, body posture and standing balance characteristics of adolescent able-bodied and idiopathic scoliosis girls.
por: Georgios A Stylianides, et al.
Publicado: (2013)

Schroth exercises improve health-related quality of life and radiographic parameters in adolescent idiopathic scoliosis patients
por: Ang Gao, et al.
Publicado: (2021)

Evaluation of Quality of Life (QoL) of Patients with Adolescent Idiopathic Scoliosis (AIS) after Surgical Correction
por: Mohamed A Abdelaziz, MD., et al.
Publicado: (2020)

A comparison of foot posture and walking performance in patients with mild, moderate, and severe adolescent idiopathic scoliosis.
por: Feilong Zhu, et al.
Publicado: (2021)

Identification of a susceptibility locus for severe adolescent idiopathic scoliosis on chromosome 17q24.3.
por: Atsushi Miyake, et al.
Publicado: (2013)

What a stranded whale with scoliosis can teach us about human idiopathic scoliosis
por: Steven de Reuver, et al.
Publicado: (2021)

Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
por: Wang N, et al.
Publicado: (2019)

Structural basis for an exceptionally strong preference for asparagine residue at the S2 subsite of Stenotrophomonas maltophilia dipeptidyl peptidase 7
por: Akihiro Nakamura, et al.
Publicado: (2021)

Natural dipeptidyl peptidase-IV inhibitor mangiferin mitigates diabetes- and metabolic syndrome-induced changes in experimental rats
por: Suman RK, et al.
Publicado: (2016)

A Pragmatic Benchmarking Study of an Evidence-Based Personalised Approach in 1938 Adolescents with High-Risk Idiopathic Scoliosis
por: Stefano Negrini, et al.
Publicado: (2021)